nifedipine has been researched along with Bronchopulmonary Dysplasia in 6 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A two-year-old child dying of pulmonary hypertension and cor pulmonale secondary to bronchopulmonary dysplasia, was demonstrated to have reactive pulmonary hypertension in response to 100% oxygen and isoproterenol infusion." | 9.06 | Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia. ( Bingham, WT; Duncan, WJ; Kasian, GF; Mersal, A; Ninan, A; Sankaran, K; Tyrrell, MJ, 1988) |
| "The pharmacokinetics and associated pharmacodynamics of nifedipine were studied in nine children aged 5 to 68 mo with bronchopulmonary dysplasia and pulmonary artery hypertension after a single oral dose of 1." | 7.68 | Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension. ( Amidon, GL; Beekman, RH; Johnson, CE; Kostyshak, DA; Nguyen, T; Oh, DM, 1991) |
| "The acute hemodynamic effects of nifedipine were evaluated and compared to the effects of 95% oxygen in six children with bronchopulmonary dysplasia and pulmonary artery hypertension." | 7.67 | Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension. ( Beekman, RH; Brownlee, JR; Rosenthal, A, 1988) |
| "A two-year-old child dying of pulmonary hypertension and cor pulmonale secondary to bronchopulmonary dysplasia, was demonstrated to have reactive pulmonary hypertension in response to 100% oxygen and isoproterenol infusion." | 5.06 | Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia. ( Bingham, WT; Duncan, WJ; Kasian, GF; Mersal, A; Ninan, A; Sankaran, K; Tyrrell, MJ, 1988) |
| "The pharmacokinetics and associated pharmacodynamics of nifedipine were studied in nine children aged 5 to 68 mo with bronchopulmonary dysplasia and pulmonary artery hypertension after a single oral dose of 1." | 3.68 | Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension. ( Amidon, GL; Beekman, RH; Johnson, CE; Kostyshak, DA; Nguyen, T; Oh, DM, 1991) |
| "The acute hemodynamic effects of nifedipine were evaluated and compared to the effects of 95% oxygen in six children with bronchopulmonary dysplasia and pulmonary artery hypertension." | 3.67 | Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension. ( Beekman, RH; Brownlee, JR; Rosenthal, A, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosati, E | 1 |
| Butera, G | 1 |
| Bossone, E | 1 |
| De Felice, C | 1 |
| Latini, G | 1 |
| Johnson, CE | 1 |
| Beekman, RH | 2 |
| Kostyshak, DA | 1 |
| Nguyen, T | 1 |
| Oh, DM | 1 |
| Amidon, GL | 1 |
| Davis, JM | 1 |
| Sinkin, RA | 1 |
| Aranda, JV | 1 |
| Brownlee, JR | 1 |
| Rosenthal, A | 1 |
| Kasian, GF | 1 |
| Ninan, A | 1 |
| Duncan, WJ | 1 |
| Bingham, WT | 1 |
| Mersal, A | 1 |
| Tyrrell, MJ | 1 |
| Sankaran, K | 1 |
| Kochanek, PM | 1 |
| Zaritsky, A | 1 |
1 review available for nifedipine and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Drug therapy for bronchopulmonary dysplasia.
Topics: Bronchodilator Agents; Bronchopulmonary Dysplasia; Diuretics; Humans; Infant, Newborn; Nifedipine | 1990 |
1 trial available for nifedipine and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia.
Topics: Albuterol; Bronchopulmonary Dysplasia; Child, Preschool; Diltiazem; Humans; Hydralazine; Hypertensio | 1988 |
4 other studies available for nifedipine and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Inhaled nitric oxide and oral nifedipine in a preterm infant with bronchopulmonary dysplasia and pulmonary hypertension.
Topics: Administration, Inhalation; Administration, Oral; Bronchodilator Agents; Bronchopulmonary Dysplasia; | 2007 |
Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension.
Topics: Administration, Oral; Bronchopulmonary Dysplasia; Child, Preschool; Diuretics; Female; Hemodynamics; | 1991 |
Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
Topics: Blood Pressure; Bronchopulmonary Dysplasia; Cardiac Catheterization; Cardiac Output; Child, Preschoo | 1988 |
Nifedipine in the treatment of a child with pulmonary hypertension associated with severe bronchopulmonary dysplasia.
Topics: Bronchopulmonary Dysplasia; Hemodynamics; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; | 1986 |